CARBAMAZEPINE
- Product NDC
- 63629-9296
- 11-digit product format
- 636299296
- Labeler code
- 63629
- Product ID
- 63629-9296_703cc386-86e3-4168-8afc-899e43a2dcc3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CARBAMAZEPINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA075948
- Marketing category
- ANDA
- Marketing start
- 2002-09-01
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-9296-1 | 63629929601 | 100 TABLET in 1 BOTTLE (63629-9296-1) | 100 tablet | 2022-06-06 | 0000-00-00 | No | No | Current |